Free Trial
LON:DPH

Dechra Pharmaceuticals (DPH) Share Price, News & Analysis

Dechra Pharmaceuticals logo

About Dechra Pharmaceuticals Stock (LON:DPH)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
3,866
3,866
52-Week Range
N/A
Volume
2.04 million shs
Average Volume
1.29 million shs
Market Capitalization
£4.40 billion
P/E Ratio
N/A
Dividend Yield
1.20%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dechra Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

DPH Stock News Headlines

Dechra Pharmaceuticals PLC (DPH.L)
This Could Be the Most Profitable Season of Your Life
Institutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the same point in every cycle when crypto enters its most explosive phase — and two experts are showing how to ride it. Inside The Crypto Code Workshop, you’ll get their step-by-step system and $10 in free Bitcoin for attending.
Form 8.3 - Dechra Phartmaceuticals PLC - Amendment
Dechra Pharmaceuticals PLC DPH
See More Headlines

DPH Stock Analysis - Frequently Asked Questions

Shares of DPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Dechra Pharmaceuticals investors own include 32Red (TTR), 1428686 (SGP.L) (SGP), JD Sports Fashion (JD), Ashtead Group (AHT), Rolls-Royce Holdings plc (RR.L), Cranswick (CWK) and Drax Group (DRX).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
Personal Services
Current Symbol
LON:DPH
CIK
N/A
Fax
N/A
Employees
2,457
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.25)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
1.42
Net Income
-£27.90 million
Net Margins
-3.66%
Pretax Margin
N/A
Return on Equity
-3.92%
Return on Assets
0.75%

Debt

Debt-to-Equity Ratio
66.80
Current Ratio
2.85
Quick Ratio
1.66

Sales & Book Value

Annual Sales
£761.50 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
24.43
Book Value
GBX 663 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
113,910,000
Free Float
N/A
Market Cap
£4.40 billion
Optionable
Not Optionable
Beta
0.78
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:DPH) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners